Á lódáil...
Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study
BACKGROUND: Evidence for pharmacogenetic risk stratification of angiotensin-converting enzyme inhibitor (ACEI) treatment is limited. Therefore, in a cohort of ACEI-treated patients with congestive heart failure (CHF), we investigated the predictive value of two pharmacogenetic scores that previously...
Na minha lista:
Foilsithe in: | PLoS One |
---|---|
Main Authors: | , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Public Library of Science
2015
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4669156/ https://ncbi.nlm.nih.gov/pubmed/26633885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0144195 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|